{"title": "PDF", "author": "PDF", "url": "https://www.broadinstitute.org/files/patents/WO2018035388.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Property Organization III of,orconsisting ofmethylase activity, demethylase activity, transcription activation activity, transcription repression activity, transcription releasefactoractivity,histonemodification activity,RNAcleavage activity, DNAcleavage [0305] Incertainembodiments, maximizing [0309] Incertainembodiments, optimizing ofmismatches orbulgesbetweentheRNAguideandDNAtarget.Thistolerance is concentration, lipidstructure, the compound isattached toanucleicacidintheLNP.Insomeembodiments, the shielding compound iscovalently attached tothenucleicacid.Insomeembodiments, essentially of,orconsisting ofmethylase activity, releasefactoractivity, methylase activity, demethylase activity, transcription activation activity, transcription repression activity, transcription releasefactoractivity, histone modification Thetissue-specific toeithertheirexperimentally determined orhomology models. Structural alignment isfurtherusedtoidentifybothcloseandremotestructural neighbours by considering globalandlocalgeometric relationships. Whenever twoneighbors ofthe activity, demethylase activity, transcription activation activity, transcription repression activity, transcription releasefactoractivity, histone modification activity, involved in theproduction nutritional resistance nutritional resistance Furthermore, CRISPR-based treatments characterized by impairment patterns attacks, heartfailure,andstrokeandTIA.Anychromosomal sequence involved in cardiovascular diseaseortheproteinencoded byanychromosomal sequence involved in USapplication 62/087,537, 4-Dec-14, SYSTEMS, OFTHECRISPR-CAS SYSTEMS CELL PENETRATION (CPP); SYSTEMS activity, demethylase activity, transcription andarethusnot selecting "}